Last reviewed · How we verify
Azelastine hydrochloride and Fluticasone propionate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Azelastine hydrochloride and Fluticasone propionate (Azelastine hydrochloride and Fluticasone propionate) — Teva Pharmaceuticals USA.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Azelastine hydrochloride and Fluticasone propionate TARGET | Azelastine hydrochloride and Fluticasone propionate | Teva Pharmaceuticals USA | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Azelastine hydrochloride and Fluticasone propionate CI watch — RSS
- Azelastine hydrochloride and Fluticasone propionate CI watch — Atom
- Azelastine hydrochloride and Fluticasone propionate CI watch — JSON
- Azelastine hydrochloride and Fluticasone propionate alone — RSS
Cite this brief
Drug Landscape (2026). Azelastine hydrochloride and Fluticasone propionate — Competitive Intelligence Brief. https://druglandscape.com/ci/azelastine-hydrochloride-and-fluticasone-propionate. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab